Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger G Pertwee

Showing results (91-100 of 106) with videos related to

Pageof 11
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potencyReem Smoum, Saja Baraghithy, Mukesh Chourasia, et al.
ACS Chemical Neuroscience|January 20, 2017
Enantiospecific Allosteric Modulation of Cannabinoid 1 ReceptorRobert B Laprairie, Pushkar M Kulkarni, Jeffrey R Deschamps, et al.
Elife|May 23, 2022
Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2Bitya Raphael-Mizrahi, Malka Attar-Namdar, Mukesh Chourasia, et al.
Journal of Medicinal Chemistry|November 4, 2015
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)Pushkar M Kulkarni, Abhijit R Kulkarni, Anisha Korde, et al.
ACS Chemical Neuroscience|April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding ProbeRobert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Bioorganic & Medicinal Chemistry|April 29, 2020
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activityAntonella Brizzi, Francesca Aiello, Serena Boccella, et al.
Molecular Pharmacology|August 23, 2005
Allosteric modulation of the cannabinoid CB1 receptorMartin R Price, Gemma L Baillie, Adèle Thomas, et al.
Nature Medicine|April 3, 2007
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cellsKatarzyna Maresz, Gareth Pryce, Eugene D Ponomarev, et al.
Journal of Medicinal Chemistry|July 18, 2022
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic LigandsFrancesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Chemmedchem|March 3, 2012
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approachClaudia Mugnaini, Stefania Nocerino, Valentina Pedani, et al.
Pageof 11

Showing results (91-100 of 106) with videos related to

Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2015
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potencyReem Smoum, Saja Baraghithy, Mukesh Chourasia, et al.
ACS Chemical Neuroscience|January 20, 2017
Enantiospecific Allosteric Modulation of Cannabinoid 1 ReceptorRobert B Laprairie, Pushkar M Kulkarni, Jeffrey R Deschamps, et al.
Elife|May 23, 2022
Osteogenic growth peptide is a potent anti-inflammatory and bone preserving hormone via cannabinoid receptor type 2Bitya Raphael-Mizrahi, Malka Attar-Namdar, Mukesh Chourasia, et al.
Journal of Medicinal Chemistry|November 4, 2015
Novel Electrophilic and Photoaffinity Covalent Probes for Mapping the Cannabinoid 1 Receptor Allosteric Site(s)Pushkar M Kulkarni, Abhijit R Kulkarni, Anisha Korde, et al.
ACS Chemical Neuroscience|April 6, 2016
Mapping Cannabinoid 1 Receptor Allosteric Site(s): Critical Molecular Determinant and Signaling Profile of GAT100, a Novel, Potent, and Irreversibly Binding ProbeRobert B Laprairie, Abhijit R Kulkarni, Pushkar M Kulkarni, et al.
Bioorganic & Medicinal Chemistry|April 29, 2020
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activityAntonella Brizzi, Francesca Aiello, Serena Boccella, et al.
Molecular Pharmacology|August 23, 2005
Allosteric modulation of the cannabinoid CB1 receptorMartin R Price, Gemma L Baillie, Adèle Thomas, et al.
Nature Medicine|April 3, 2007
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cellsKatarzyna Maresz, Gareth Pryce, Eugene D Ponomarev, et al.
Journal of Medicinal Chemistry|July 18, 2022
Design, Synthesis, and Biological Activity of New CB2 Receptor Ligands: from Orthosteric and Allosteric Modulators to Dualsteric/Bitopic LigandsFrancesca Gado, Rebecca Ferrisi, Beatrice Polini, et al.
Chemmedchem|March 3, 2012
Investigations on the 4-quinolone-3-carboxylic acid motif part 5: modulation of the physicochemical profile of a set of potent and selective cannabinoid-2 receptor ligands through a bioisosteric approachClaudia Mugnaini, Stefania Nocerino, Valentina Pedani, et al.
Pageof 11